Search Results - "Barker, Shannon D"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells by KANERVA, Anna, MIKHEEVA, Galina V, HEMMINKI, Akseli, CURIEL, David T, KRASNYKH, Victor, COOLIDGE, Candace J, LAM, John T, MAHASRESHTI, Parameshwar J, BARKER, Shannon D, STRAUGHN, Michael, BARNES, Mack N, ALVAREZ, Ronald D

    Published in Clinical cancer research (01-01-2002)
    “…Gene delivery efficiency in clinical cancer gene therapy trials with recombinant adenoviruses (Ads) based on serotype 5 (Ad5) has been limited partly because…”
    Get full text
    Journal Article
  2. 2

    Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer by Ono, Hidetaka A, Davydova, Julia G, Adachi, Yasuo, Takayama, Koichi, Barker, Shannon D, Reynolds, Paul N, Krasnykh, Victor N, Kunisaki, Chikara, Shimada, Hiroshi, Curiel, David T, Yamamoto, Masato

    Published in Journal of gastroenterology (01-01-2005)
    “…Gastric cancer is the fourth most common malignancy worldwide. Adenoviral vectors (Ads) have been applied for gene therapy of various cancers because of their…”
    Get full text
    Journal Article
  3. 3

    CD40 Is Expressed on Ovarian Cancer Cells and Can Be Utilized for Targeting Adenoviruses by HAKKARAINEN, Tanja, HEMMINKI, Akseli, PEREBOEV, Alexander V, BARKER, Shannon D, ASIEDU, Clement K, STRONG, Theresa V, KANERVA, Anna, WAHLFORS, Jarmo, CURIEL, David T

    Published in Clinical cancer research (01-02-2003)
    “…Purpose: CD40, a member of the tumor necrosis factor receptor superfamily, is widely expressed on various cell types in addition to hematopoietic cells. Recent…”
    Get full text
    Journal Article
  4. 4

    The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy by Barker, Shannon D., Coolidge, Candace J., Kanerva, Anna, Hakkarainen, Tanja, Yamamoto, Masato, Liu, Bin, Rivera, Angel A., Bhoola, Snehal M., Barnes, Mack N., Alvarez, Ronald D., Curiel, David T., Hemminki, Akseli

    Published in The journal of gene medicine (01-04-2003)
    “…Background Adenoviruses allow efficient transduction of dividing and non‐dividing cells and their safety for the treatment of cancer has been established in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review) by Bauerschmitz, Gerd J, Barker, Shannon D, Hemminki, Akseli

    Published in International journal of oncology (01-12-2002)
    “…Gene therapy is an exciting novel approach for treating cancers resistant to currently available modalities. Treatment approaches are based on taking advantage…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing by Pratt, Victoria M, Caggana, Michele, Bridges, Christina, Buller, Arlene M, DiAntonio, Lisa, Highsmith, W. Edward, Holtegaard, Leonard M, Muralidharan, Kasinathan, Rohlfs, Elizabeth M, Tarleton, Jack, Toji, Lorraine, Barker, Shannon D, Kalman, Lisa V

    Published in The Journal of molecular diagnostics : JMD (01-05-2009)
    “…The number of different laboratories that perform genetic testing for cystic fibrosis is increasing. However, there are a limited number of quality control and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids by Lam, John T, Bauerschmitz, Gerd J, Kanerva, Anna, Barker, Shannon D, Straughn, J Michael, Wang, Minghui, Barnes, Mack N, Blackwell, Jerry L, Siegal, Gene P, Alvarez, Ronald D, Curiel, David T, Hemminki, Akseli

    Published in Cancer gene therapy (01-05-2003)
    “…Replication competent viruses hold promise for treatment of advanced cancers resistant to available therapeutic modalities. Although preliminary clinical…”
    Get full text
    Journal Article